$BKYI
BIO KEY INTERNATIONAL INC

2017 Q1 Form 10-K Financial Statement

#000143774917005802 Filed on March 31, 2017

View on sec.gov

Income Statement

Concept 2017 Q1 2016 2015 Q4
Revenue $1.418M $2.976M $1.670M
YoY Change 229.39% -43.44% 75.79%
Cost Of Revenue $660.9K $729.7K $620.0K
YoY Change 490.92% -42.97% 169.57%
Gross Profit $757.4K $2.246M $1.050M
YoY Change 137.62% -43.59% 43.84%
Gross Profit Margin 53.4% 75.48% 62.87%
Selling, General & Admin $1.620M $4.439M $1.090M
YoY Change 63.24% 7.69% 17.2%
% of Gross Profit 213.91% 197.63% 103.81%
Research & Development $493.4K $2.009M $390.0K
YoY Change 0.83% 29.11% 14.71%
% of Gross Profit 65.15% 89.44% 37.14%
Depreciation & Amortization $7.819K $49.04K $10.00K
YoY Change -32.11% 14.05% 0.0%
% of Gross Profit 1.03% 2.18% 0.95%
Operating Expenses $2.114M $6.448M $1.470M
YoY Change 42.62% 13.56% 15.75%
Operating Profit -$1.356M -$4.202M -$420.0K
YoY Change 16.59% 147.71% -22.22%
Interest Expense $0.00 -$180.0K
YoY Change -550.0%
% of Operating Profit
Other Income/Expense, Net $6.00 $12.12K
YoY Change -118.75% -107.48%
Pretax Income -$1.360M -$4.190M -$610.0K
YoY Change 17.24% 125.27% 19.61%
Income Tax -$12.12K $0.00
% Of Pretax Income
Net Earnings -$1.356M -$4.190M -$610.0K
YoY Change 16.59% 125.58% 19.61%
Net Earnings / Revenue -95.62% -140.79% -36.53%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.789M -$5.986M -$884.1K
COMMON SHARES
Basic Shares Outstanding 6.097M
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q1 2016 2015 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.160M $1.060M $4.320M
YoY Change -66.57% -75.46% 414.29%
Cash & Equivalents $1.158M $1.060M $4.321M
Short-Term Investments
Other Short-Term Assets $117.9K $1.770M $37.42K
YoY Change -19.86% -65.29% -51.18%
Inventory $571.0K $470.0K $168.6K
Prepaid Expenses
Receivables $562.5K $1.560M $3.391M
Other Receivables $120.0K $60.00K $40.00K
Total Short-Term Assets $4.407M $4.910M $13.02M
YoY Change -61.36% -62.8% 625.56%
LONG-TERM ASSETS
Property, Plant & Equipment $60.00K $70.00K $63.88K
YoY Change -16.26% 16.67% -38.29%
Goodwill
YoY Change
Intangibles $144.6K $147.7K
YoY Change 0.2% -8.43%
Long-Term Investments
YoY Change
Other Assets $10.00K $10.00K $10.00K
YoY Change 0.0% 0.0% 0.0%
Total Long-Term Assets $11.22M $12.38M $7.400M
YoY Change 55.26% 71.47% 2605.14%
TOTAL ASSETS
Total Short-Term Assets $4.407M $4.910M $13.02M
Total Long-Term Assets $11.22M $12.38M $7.400M
Total Assets $15.62M $17.29M $20.42M
YoY Change -16.13% -15.33% 887.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $153.7K $470.0K $1.159M
YoY Change -75.55% -59.48% 233.58%
Accrued Expenses $380.0K $340.0K $493.1K
YoY Change 21.77% -46.03% 0.91%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.625M $1.840M $2.266M
YoY Change -4.45% -18.94% 73.2%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.625M $1.840M $2.266M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.625M $1.840M $2.266M
YoY Change -4.45% -18.94% 73.2%
SHAREHOLDERS EQUITY
Retained Earnings -$64.16M -$58.61M
YoY Change 7.33% 3.27%
Common Stock $610.00 $551.00
YoY Change -90.79% -91.65%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $14.00M $15.45M $18.15M
YoY Change
Total Liabilities & Shareholders Equity $15.62M $17.29M $20.42M
YoY Change -16.13% -15.33% 887.5%

Cashflow Statement

Concept 2017 Q1 2016 2015 Q4
OPERATING ACTIVITIES
Net Income -$1.356M -$4.190M -$610.0K
YoY Change 16.59% 125.58% 19.61%
Depreciation, Depletion And Amortization $7.819K $49.04K $10.00K
YoY Change -32.11% 14.05% 0.0%
Cash From Operating Activities $117.0K -$4.447M -$14.59M
YoY Change -117.68% -71.42% 1723.75%
INVESTING ACTIVITIES
Capital Expenditures $13.89K $52.98K $0.00
YoY Change -27.97% 1474.76% -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$13.89K -$52.98K $0.00
YoY Change -27.97% 1474.76% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $1.860M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -5.946K 1.240M 18.84M
YoY Change -96.41% -93.49% 1164.43%
NET CHANGE
Cash From Operating Activities 117.0K -4.447M -14.59M
Cash From Investing Activities -13.89K -52.98K 0.000
Cash From Financing Activities -5.946K 1.240M 18.84M
Net Change In Cash 97.11K -3.260M 4.250M
YoY Change -111.47% -193.74% 525.0%
FREE CASH FLOW
Cash From Operating Activities $117.0K -$4.447M -$14.59M
Capital Expenditures $13.89K $52.98K $0.00
Free Cash Flow $103.1K -$4.500M -$14.59M
YoY Change -115.14% -71.09% 1746.84%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016 dei Entity Central Index Key
EntityCentralIndexKey
0001019034
CY2016 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2017Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6096920
CY2016 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2016 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2016 dei Trading Symbol
TradingSymbol
bkyi
CY2016 dei Entity Registrant Name
EntityRegistrantName
BIO KEY INTERNATIONAL INC
CY2016 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2016 bkyi Amortization Of Software License Rights
AmortizationOfSoftwareLicenseRights
21589
CY2015 bkyi Amortization Of Software License Rights
AmortizationOfSoftwareLicenseRights
CY2015 bkyi Class Of Warrant Or Right Grants In Period
ClassOfWarrantOrRightGrantsInPeriod
117362
CY2016 bkyi Class Of Warrant Or Right Grants In Period
ClassOfWarrantOrRightGrantsInPeriod
CY2016 bkyi Class Of Warrant Or Right Nonemployee Compensation Expense
ClassOfWarrantOrRightNonemployeeCompensationExpense
11625
CY2015 bkyi Class Of Warrant Or Right Nonemployee Compensation Expense
ClassOfWarrantOrRightNonemployeeCompensationExpense
51026
CY2016 bkyi Effective Income Tax Reconciliation Effect Of Net Operating Loss
EffectiveIncomeTaxReconciliationEffectOfNetOperatingLoss
-0.34
CY2015 bkyi Effective Income Tax Reconciliation Effect Of Net Operating Loss
EffectiveIncomeTaxReconciliationEffectOfNetOperatingLoss
-0.34
CY2016 bkyi Effective Income Tax Reconciliation Permanent Differences
EffectiveIncomeTaxReconciliationPermanentDifferences
CY2015 bkyi Effective Income Tax Reconciliation Permanent Differences
EffectiveIncomeTaxReconciliationPermanentDifferences
CY2016Q4 bkyi Factored Accounts Receivable Factored Amount
FactoredAccountsReceivableFactoredAmount
160918
CY2015Q4 bkyi Factored Accounts Receivable Factored Amount
FactoredAccountsReceivableFactoredAmount
112259
CY2016 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2016 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016 dei Document Period End Date
DocumentPeriodEndDate
2016-12-31
CY2016 dei Document Type
DocumentType
10-K
CY2016Q2 dei Entity Public Float
EntityPublicFloat
15629687
CY2016 dei Amendment Flag
AmendmentFlag
false
CY2016 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2016 bkyi Warrants Outstanding Weighted Average Remaining Life
WarrantsOutstandingWeightedAverageRemainingLife
P2Y284D
CY2016Q4 bkyi Warrants Vested Or Expected To Vest
WarrantsVestedOrExpectedToVest
1260080
CY2016Q4 bkyi Factored Accounts Receivable Original Invoice Value
FactoredAccountsReceivableOriginalInvoiceValue
214556
CY2015Q4 bkyi Factored Accounts Receivable Original Invoice Value
FactoredAccountsReceivableOriginalInvoiceValue
149680
CY2011Q4 bkyi Factoring Arrangement Term
FactoringArrangementTerm
P2Y
CY2016 bkyi Factoring Fees
FactoringFees
341023
CY2015 bkyi Factoring Fees
FactoringFees
383629
CY2016 bkyi Increase Decrease In Software License Rights
IncreaseDecreaseInSoftwareLicenseRights
CY2015 bkyi Increase Decrease In Software License Rights
IncreaseDecreaseInSoftwareLicenseRights
12000000
CY2016 bkyi Operational Costs Per Month
OperationalCostsPerMonth
592000
CY2016 bkyi Percentage Of Remaining Balance Owned Reserved
PercentageOfRemainingBalanceOwnedReserved
0.24
CY2016 bkyi Reclassification Of Derivative Liability To Additional Paid In Capital
ReclassificationOfDerivativeLiabilityToAdditionalPaidInCapital
92199
CY2015 bkyi Reclassification Of Derivative Liability To Additional Paid In Capital
ReclassificationOfDerivativeLiabilityToAdditionalPaidInCapital
CY2016Q4 bkyi Software License Rights Current
SoftwareLicenseRightsCurrent
1560000
CY2015Q4 bkyi Software License Rights Current
SoftwareLicenseRightsCurrent
5000000
CY2016Q4 bkyi Software License Rights Noncurrent
SoftwareLicenseRightsNoncurrent
10598411
CY2015Q4 bkyi Software License Rights Noncurrent
SoftwareLicenseRightsNoncurrent
7180000
CY2016Q4 bkyi Sotware License Rights
SotwareLicenseRights
12158411
CY2015Q4 bkyi Sotware License Rights
SotwareLicenseRights
12000000
CY2016 bkyi Stock Based Fees To Directors And Consulants
StockBasedFeesToDirectorsAndConsulants
167000
CY2015 bkyi Stock Based Fees To Directors And Consulants
StockBasedFeesToDirectorsAndConsulants
17000
CY2015Q1 bkyi Term Of Warrant
TermOfWarrant
P1Y
CY2015 bkyi Total Warrants Exercised
TotalWarrantsExercised
CY2016 bkyi Total Warrants Exercised
TotalWarrantsExercised
CY2015 bkyi Total Warrants Expired
TotalWarrantsExpired
CY2016 bkyi Total Warrants Expired
TotalWarrantsExpired
444548
CY2015 bkyi Total Warrants Forfeited
TotalWarrantsForfeited
CY2016 bkyi Total Warrants Forfeited
TotalWarrantsForfeited
CY2016Q4 bkyi Warrants Exercisable
WarrantsExercisable
1260080
CY2016Q4 bkyi Warrants Exercisable Weighted Average Exercise Price
WarrantsExercisableWeightedAverageExercisePrice
3.84
CY2016 bkyi Warrants Exercisable Weighted Average Remaining Life
WarrantsExercisableWeightedAverageRemainingLife
P2Y284D
CY2014Q4 bkyi Warrants Outstanding Exercise Price
WarrantsOutstandingExercisePrice
4.44
CY2015Q4 bkyi Warrants Outstanding Exercise Price
WarrantsOutstandingExercisePrice
4.40
CY2016Q4 bkyi Warrants Outstanding Exercise Price
WarrantsOutstandingExercisePrice
3.84
CY2014 bkyi Warrants Outstanding Weighted Average Remaining Life
WarrantsOutstandingWeightedAverageRemainingLife
P3Y332D
CY2015 bkyi Warrants Outstanding Weighted Average Remaining Life
WarrantsOutstandingWeightedAverageRemainingLife
P3Y7D
CY2015Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
3405190
CY2016Q4 us-gaap Accounts Receivable Gross Noncurrent
AccountsReceivableGrossNoncurrent
2070000
CY2015Q4 us-gaap Accounts Receivable Gross Noncurrent
AccountsReceivableGrossNoncurrent
CY2016Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
3133246
CY2015Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
3391405
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1563246
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3391405
CY2016Q4 bkyi Warrants Vested Or Expected To Vest Weighted Average Exercise Price
WarrantsVestedOrExpectedToVestWeightedAverageExercisePrice
3.84
CY2016 bkyi Warrants Vested Or Expected To Vest Weighted Average Remaining Life
WarrantsVestedOrExpectedToVestWeightedAverageRemainingLife
P2Y284D
CY2015 bkyi Weighted Average Exercise Price Warrants Exercised
WeightedAverageExercisePriceWarrantsExercised
CY2016 bkyi Weighted Average Exercise Price Warrants Exercised
WeightedAverageExercisePriceWarrantsExercised
CY2015 bkyi Weighted Average Exercise Price Warrants Expired
WeightedAverageExercisePriceWarrantsExpired
CY2016 bkyi Weighted Average Exercise Price Warrants Expired
WeightedAverageExercisePriceWarrantsExpired
6
CY2015 bkyi Weighted Average Exercise Price Warrants Forfeited
WeightedAverageExercisePriceWarrantsForfeited
CY2016 bkyi Weighted Average Exercise Price Warrants Forfeited
WeightedAverageExercisePriceWarrantsForfeited
CY2015 bkyi Weighted Average Exercise Price Warrants Granted
WeightedAverageExercisePriceWarrantsGranted
3.16
CY2016 bkyi Weighted Average Exercise Price Warrants Granted
WeightedAverageExercisePriceWarrantsGranted
CY2016Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
53638
CY2015Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
37421
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
466842
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1158555
CY2016Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
3647031
CY2015Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
3405190
CY2016Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1577031
CY2016Q4 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
1570000
CY2015Q4 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
335323
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
493067
CY2016Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
79633
CY2015Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
141000
CY2016Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
66152
CY2015Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
78016
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
553126
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
557384
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
78253413
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
76760796
CY2016 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
92199
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
273089
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
260842
CY2015 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
459102
CY2016 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
84866
CY2015 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
51026
CY2016Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1260080
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016 us-gaap Advertising Expense
AdvertisingExpense
299000
CY2015 us-gaap Advertising Expense
AdvertisingExpense
339000
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
340341
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
341115
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
13785
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
13785
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Noncurrent
AllowanceForDoubtfulAccountsReceivableNoncurrent
500000
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Noncurrent
AllowanceForDoubtfulAccountsReceivableNoncurrent
CY2016 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
CY2015 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
92199
CY2016 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
13606
CY2015 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
13606
CY2016Q4 us-gaap Assets
Assets
17289365
CY2015Q4 us-gaap Assets
Assets
20416079
CY2016Q4 us-gaap Assets Current
AssetsCurrent
4910296
CY2015Q4 us-gaap Assets Current
AssetsCurrent
13015752
CY2016Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
12379069
CY2015Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
7400327
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1061307
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4321078
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
843632
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3259771
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
3477446
CY2016Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
811000
CY2015Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
4073000
CY2015Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.52
CY2015Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
47917
CY2014Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1587266
CY2015Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1704628
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
609
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
551
CY2016Q4 us-gaap Compensated Absences Liability
CompensatedAbsencesLiability
154368
CY2015Q4 us-gaap Compensated Absences Liability
CompensatedAbsencesLiability
113996
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
170000000
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
170000000
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6093843
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5508261
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6093843
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5508261
CY2016 us-gaap Cost Of Revenue
CostOfRevenue
729683
CY2015 us-gaap Cost Of Revenue
CostOfRevenue
1279521
CY2016 us-gaap Cost Of Services
CostOfServices
216465
CY2015 us-gaap Cost Of Services
CostOfServices
260436
CY2016Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
633062
CY2015Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
376405
CY2016Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
60000
CY2015Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
55000
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
18597000
CY2016Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
401250
CY2015Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
133851
CY2016Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
401250
CY2015Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
133851
CY2015 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
133851
CY2016 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
802500
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.89
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.36
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
17994000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
67000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
75000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
360000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
258000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
202000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
5000
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
19278000
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
18371000
CY2016Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
8000
CY2015Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
16000
CY2016 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2015 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2016Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
8712
CY2015Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
8712
CY2016 us-gaap Depreciation
Depreciation
49038
CY2015 us-gaap Depreciation
Depreciation
42996
CY2016 us-gaap Derivatives Embedded Derivatives
DerivativesEmbeddedDerivatives
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14.</div>&nbsp;<div style="display: inline; font-style: italic;">Derivative Liabilities</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In connection with the issuances of equity instruments or debt, the Company <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> issue options or warrants to purchase common stock. In certain circumstances, these options or warrants <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> be classified as liabilities, rather than as equity. In addition, the equity instrument or debt <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> contain embedded derivative instruments, such as conversion options or listing requirements, which in certain circumstances <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> be required to be bifurcated from the associated host instrument and accounted for separately as a derivative liability instrument. The Company accounts for derivative liability instruments under the provisions of FASB ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">815,</div> &#x201c;Derivatives and Hedging.&#x201d;</div></div></div></div></div>
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
CY2015 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2016 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y65D
CY2016Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
166146
CY2016 us-gaap Gross Profit
GrossProfit
2246073
CY2015 us-gaap Gross Profit
GrossProfit
3981704
CY2016Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
153116
CY2015Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
139510
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
35000
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
13000
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
13000
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
13000
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
13000
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
13000
CY2016Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
287248
CY2015Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
287248
CY2016Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
134132
CY2015Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
147738
CY2016 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
12085
CY2015 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
31142
CY2016 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
12085
CY2015 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
31142
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-12115
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
161043
CY2016 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-691713
CY2015 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
811244
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
241841
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2759323
CY2016 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-157745
CY2015 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4450
CY2016 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
256657
CY2015 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-52828
CY2016 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
296783
CY2015 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
336820
CY2016 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
16217
CY2015 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-39236
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
109474
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-139226
CY2016Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
134132
CY2015Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
147738
CY2016 us-gaap Interest Expense
InterestExpense
CY2015 us-gaap Interest Expense
InterestExpense
192199
CY2016 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
30
CY2015 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
14
CY2016 us-gaap Interest Paid
InterestPaid
CY2015 us-gaap Interest Paid
InterestPaid
100000
CY2016Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
381762
CY2015Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
66475
CY2016Q4 us-gaap Inventory Net
InventoryNet
465428
CY2015Q4 us-gaap Inventory Net
InventoryNet
168645
CY2016Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
83666
CY2015Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
102170
CY2016 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
CY2015 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
92199
CY2016Q4 us-gaap Liabilities
Liabilities
1836477
CY2015Q4 us-gaap Liabilities
Liabilities
2266162
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17289365
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20416079
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1836477
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2266162
CY2016 us-gaap License Costs
LicenseCosts
513218
CY2015 us-gaap License Costs
LicenseCosts
1019085
CY2016 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1240034
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
19040898
CY2016 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-52975
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-3364
CY2016 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-4446830
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-15560088
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-4189704
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-1857306
CY2016 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4992204
CY2015 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1991157
CY2016 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2016 us-gaap Operating Expenses
OperatingExpenses
6447892
CY2015 us-gaap Operating Expenses
OperatingExpenses
5677967
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-4201819
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-1696263
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
268940
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
165111
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
103829
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
8182
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
111800
CY2016Q4 us-gaap Other Assets Current
OtherAssetsCurrent
53638
CY2015Q4 us-gaap Other Assets Current
OtherAssetsCurrent
37421
CY2016 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
2154578
CY2015 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
4329831
CY2016 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
535100
CY2015 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
CY2016 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
84866
CY2015 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
459102
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
52975
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3364
CY2015Q4 us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
180000
CY2015 us-gaap Revenues
Revenues
5261225
CY2016 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
802500
CY2015 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
133851
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
206677
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
97203
CY2016 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18.</div>&nbsp; Reclassifications</div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;</div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt">Reclassifications occurred to certain prior year amounts in order to conform to the current year classifications. The reclassifications have no effect on the reported net loss. </div></div></div></div>
CY2016 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1860000
CY2015 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
CY2016 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
CY2015 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
19500000
CY2016 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
CY2015 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
250000
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
620940
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
621261
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
67814
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
63877
CY2016 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
500000
CY2015 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-6741
CY2016 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
CY2015 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
250000
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2008942
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1556025
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-62801154
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-58611450
CY2016 us-gaap Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10.</div>&nbsp;<div style="display: inline; font-style: italic;">Deferred Revenue</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Deferred revenue includes customer advances and amounts that have been billed per the contractual terms but have not been recognized as revenue. The majority of these amounts are related to maintenance contracts for which the revenue is recognized ratably over the applicable term, which generally is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12</div> months from the date the customer is delivered the products.</div></div></div></div></div>
CY2016 us-gaap Revenues
Revenues
2975756
CY2016Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
26988
CY2015Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
48255
CY2016 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
821178
CY2015 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
931394
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
216566
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.56
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
53343
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
39935
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
42004
CY2016 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4438950
CY2015 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4121942
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
260842
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
324115
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.93
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.17
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0111
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0146
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
10419
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
27087
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
119000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.86
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.68
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
240
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
53936
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
341277
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
364930
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
341663
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.32
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.87
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.99
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
41816
CY2016 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2015 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2016 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
105000
CY2015 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
19500000
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y14D
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
285430
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
265247
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
307164
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
4.16
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
3
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
2.50
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.72
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.16
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.16
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.74
CY2016 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
1.90
CY2016Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
216566
CY2016Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
341663
CY2016 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
11.04
CY2016Q4 us-gaap Share Price
SharePrice
2.65
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y182D
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y182D
CY2016Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
17367
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y186D
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y208D
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y83D
CY2016 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1860000
CY2015 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
17000
CY2016 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
62000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
15452888
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
18149917
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
759061
CY2016Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2015Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2016 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.</div> <div style="display: inline; font-style: italic;">Use of Estimates</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Our consolidated financial statements are prepared in accordance with GAAP as set forth in the Financial Accounting Standards Board&#x2019;s (FASB) Accounting Standards Codification (ASC) and consider the various staff accounting bulletins and other applicable guidance issued by the U.S. Securities and Exchange Commission (SEC). These accounting principles require us to make certain estimates, judgments and assumptions. The Company believes that the estimates, judgments and assumptions upon which it relies are reasonable based upon information available to us at the time that these estimates, judgments and assumptions are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented. To the extent there are material differences between these estimates, judgments or assumptions and actual results, its consolidated financial statements will be affected. In many cases, the accounting treatment of a particular transaction is specifically dictated by GAAP and does not require management&#x2019;s judgment in its application. There are also areas in which management&#x2019;s judgment in selecting among available alternatives would not produce a materially different result.</div></div></div></div></div>
CY2016Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
CY2015Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
104284
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5587144
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5502778

Files In Submission

Name View Source Status
0001437749-17-005802-index-headers.html Edgar Link pending
0001437749-17-005802-index.html Edgar Link pending
0001437749-17-005802.txt Edgar Link pending
0001437749-17-005802-xbrl.zip Edgar Link pending
bkyi-20161231.xml Edgar Link completed
bkyi-20161231.xsd Edgar Link pending
bkyi-20161231_cal.xml Edgar Link unprocessable
bkyi-20161231_def.xml Edgar Link unprocessable
bkyi-20161231_lab.xml Edgar Link unprocessable
bkyi-20161231_pre.xml Edgar Link unprocessable
bkyi20161231_10k.htm Edgar Link pending
ex23-1.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending